Insurance Reimbursement

EarlyCDT^® and Your Insurance

At this time, non-US insurance carriers do not cover EarlyCDT^®; however, you may wish to contact your insurance company to discuss whether the opportunity for assistance exists.

EarlyCDT^® is a moderately-priced investment in return for comfort and peace of mind regarding one's health. It offers reassurance regardless of whether the results are negative or positive. Knowledge is power—the earlier you know about a serious health threat like cancer, the more power you have to be cured.

Oncimmune^® is currently establishing the key components, namely peer-reviewed publications, healthcare economic modeling and physician/patient advocacy needed to secure reimbursement from the dozens of private and public insurers. Once these components are successfully established in the next few months, Oncimmune^® will be well positioned to pursue reimbursement.